CN103735570A - 一种预防口腔真菌感染的口腔护理液 - Google Patents

一种预防口腔真菌感染的口腔护理液 Download PDF

Info

Publication number
CN103735570A
CN103735570A CN201310755425.9A CN201310755425A CN103735570A CN 103735570 A CN103735570 A CN 103735570A CN 201310755425 A CN201310755425 A CN 201310755425A CN 103735570 A CN103735570 A CN 103735570A
Authority
CN
China
Prior art keywords
vitamin
oral
nursing liquid
oral nursing
fungal infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310755425.9A
Other languages
English (en)
Inventor
刘维
奚苗苗
孙静
刘芳娥
李锐
张艳妮
段佳林
周新民
尹芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fourth Military Medical University FMMU
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CN201310755425.9A priority Critical patent/CN103735570A/zh
Publication of CN103735570A publication Critical patent/CN103735570A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明公开了一种口腔护理液,其包含1~5%碳酸氢钠,0.006~0.02%维生素B1,0.003~0.02%维生素B2,0.0004~0.002%维生素B6,0.02~0.1%烟酰胺,0.002~0.01%泛酸钙,制霉素是50000-200000万单位/100kg,余量为水。本发明具广谱抗真菌作用,对念珠菌属的抗菌活性高,且局部用药浓度小,对肝肾功能不全的患者毒副作用小;本发明不仅可用于口腔局部感染的预防,还可用于真菌感染的治疗。

Description

一种预防口腔真菌感染的口腔护理液
技术领域
本发明涉及一种预防口腔真菌感染的口腔护理液,特别是一种能预防白血病、肝硬化、重型肝炎、消化道出血、肿瘤化疗后、系统性红斑狼疮和艾滋病等患者口腔真菌感染的口腔护理液,属于医药技术领域。
背景技术
人体口腔内寄居真菌等大量微生物,它们之间处于生物平衡状态,正常情况下不致病,对于白血病、肝硬化、重型肝炎、消化道出血、肿瘤化疗后、系统性红斑狼疮、艾滋病等患者因机体免疫力低下、药物干扰菌群平衡等原因,真菌容易侵入机体或异位而引起口腔感染。目前,临床上使用的漱口液种类繁多,常见的有5%碳酸氢钠溶液、复方氯已定含漱液、口洁灵等。这些漱口液应用范围广,适用于多种常见的口腔疾病,但这些口腔护理液用于预防口腔真菌感染并未取得特别明确和显著的效果。
发明内容
本发明的目的是提供一种预防口腔真菌感染的口腔护理液,该护理液对易造成口腔真菌感染患者的口腔健康起到预防和保护的作用,对已有口腔真菌感染的症状起到缓解作用,以克服现有的口腔护理液不能有效控制患者口腔真菌感染的不足。
本发明实现过程如下:
一种口腔护理液,包含以下组分,各组分重量百分含量为:1~5% 碳酸氢钠, 0.006~0.02% 维生素B1,0.003~0.02% 维生素B2, 0.0004~0.002% 维生素B6,0.02~0.1%烟酰胺,0.002~0.01% 泛酸钙,制霉素是50000-200000万单位/100kg,余量为水。
上述口腔护理液各组分优选的重量百分含量为:1~4% 碳酸氢钠, 0.006~0.018% 维生素B1,0.003~0.01% 维生素B2, 0.0004~0.0012% 维生素B6,0.02~0.06%烟酰胺,0.002~0.006% 泛酸钙,制霉素是50000-200000万单位/100kg,余量为水。
进一步的,上述口腔护理液还包含有0.05%-5% 甜味剂,1%-10% 增稠剂,0.05%-1% 香精,0.05%-0.3% 抑菌剂,0.01%-5% pH调节剂。所述增稠剂是甘油,甜味剂选自山梨醇、阿斯巴甜、糖精钠,香精选自L-薄荷脑或果味香精,抑菌剂选自西吡氯胺、洗必泰或SAP,pH调节剂选自磷酸二氢钠或磷酸氢二钠。
上述口腔护理液可预防或治疗口腔溃疡病、口腔黏膜白斑和口腔真菌感染。
本发明的优点及积极效果:
1、本发明具广谱抗真菌作用,对念珠菌属的抗菌活性高,且局部用药浓度小,对肝肾功能不全的患者毒副作用小;
2、本发明添加碳酸氢钠可以改变微生物的酸性环境,从而达到抑菌的目的;
3、本发明可防治口角炎、舌炎,有利于口腔粘膜的完整性;
4、本发明不仅可用于口腔局部感染的预防,还可用于真菌感染的治疗。
具体实施方式
下面结合实例对本发明的口腔护理液做详细说明。
本发明的口腔护理液是由具有抗真菌、改变口腔酸性环境、促进口腔黏膜生长为主要功效成分的西药辅以口感调配剂混合调制而成。
实施例1(以配制100kg为例)
碳酸氢钠                                2%
制霉素                                     100000万单位
维生素B1                               0.006%
维生素B2                               0.005%
维生素B6                               0.0006%
烟酰胺                                     0.03%
泛酸钙                                     0.003%
纯化水                                     余量。
实施例2(以配制100kg为例)
碳酸氢钠                                4%
制霉素                                     50000万单位
维生素B1                               0.018%
维生素B2                               0.01%
维生素B6                               0.0012%
烟酰胺                                     0.06%
泛酸钙                                     0.006%
阿斯巴甜                                0.2%
甘油                                          8%
果味香精                                0.2%
洗必泰                                     0.02%
磷酸二氢钠                            0.4%
纯化水                                     余量。
实施例3(以配制100kg为例)
碳酸氢钠                                3%
制霉素                                     200000万单位
维生素B1                               0.009%
维生素B2                               0.006%
维生素B6                               0.0006%
烟酰胺                                     0.03%
泛酸钙                                     0.003%
山梨醇                                     3.0%
甘油                                          4.0%
L-薄荷脑                                 0.5%
西吡氯铵                                0.04%
磷酸二氢钠                            0.3%
纯化水                                     余量。
实施例4
选取志愿者共120例,这些志愿者分别为肝硬化、重型肝炎、消化道出血、肿瘤化疗后的患者,随机抽取,其中使用实施例2口腔护理液的志愿患者60例,另有志愿患者60例作为对照组使用复方氯己定漱口液,这两组患者每天各用各组选定口腔护理液进行漱口数次,共观察14天,观察结果表明:使用本发明口腔护理液的患者溃疡面不再发红的有55例,有效率为92%,其余5例改善效果不明显;使用过程中长有口腔黏膜白斑的有4例,有效率为93%,其余56例患者均未见口腔黏膜白斑生长;使用过程中咽拭子培养结果培养出真菌的有1例,有效率为98.3%,其余59例均未培养出真菌;口臭改善很明显的有60例,有效率为100%;。
使用复方氯己定漱口液的患者溃疡面不再发红的有40例,有效率为67%,其余20例改善效果不明显;使用过程中长有口腔黏膜白斑的有28例,有效率为47%,其余32例患者口腔内均长出1-3个大小不等的口腔黏膜白斑,或有白斑的未得到明显改善;使用过程中咽拭子培养结果培养出真菌的有8例,有效率为86.6%,其余52例未培养出真菌;口臭改善很明显的有60例,有效率为100%;。
总体来说,本发明对口腔真菌感染的预防和抑制较之复方氯己定漱口液有很明显的效果,平均有效率为98.3%,对口腔清洁及改善口腔异味有效率为100%。

Claims (7)

1.一种口腔护理液,其特征在于包含以下组分,各组分重量百分含量为:1~5% 碳酸氢钠, 0.006~0.02% 维生素B1,0.003~0.02% 维生素B2, 0.0004~0.002% 维生素B6,0.02~0.1%烟酰胺,0.002~0.01% 泛酸钙,制霉素是50000-200000万单位/100kg,余量为水。
2.根据权利要求1所述的口腔护理液,其特征在于各组分重量百分含量为:1~4% 碳酸氢钠, 0.006~0.018% 维生素B1,0.003~0.01% 维生素B2, 0.0004~0.0012% 维生素B6,0.02~0.06%烟酰胺,0.002~0.006% 泛酸钙,制霉素是50000-200000万单位/100kg,余量为水。
3.根据权利要求1所述的口腔护理液,其特征在于:包含有0.05%-5% 甜味剂,1%-10% 增稠剂,0.05%-1% 香精,0.05%-0.3% 抑菌剂,0.01%-5% pH调节剂。
4.根据权利要求3所述的口腔护理液,其特征在于:所述增稠剂是甘油,甜味剂选自山梨醇、阿斯巴甜、糖精钠,香精选自L-薄荷脑或果味香精,抑菌剂选自西吡氯胺、洗必泰或SAP,pH调节剂选自磷酸二氢钠或磷酸氢二钠。
5.权利要求1至4任意之一所述的口腔护理液在制备预防或治疗口腔溃疡病药物中的应用。
6.权利要求1至4任意之一所述的口腔护理液在制备预防或治疗口腔黏膜白斑药物中的应用。
7.权利要求1至4任意之一所述的口腔护理液在制备预防或治疗口腔真菌感染药物中的应用。
CN201310755425.9A 2013-12-13 2013-12-13 一种预防口腔真菌感染的口腔护理液 Pending CN103735570A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310755425.9A CN103735570A (zh) 2013-12-13 2013-12-13 一种预防口腔真菌感染的口腔护理液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310755425.9A CN103735570A (zh) 2013-12-13 2013-12-13 一种预防口腔真菌感染的口腔护理液

Publications (1)

Publication Number Publication Date
CN103735570A true CN103735570A (zh) 2014-04-23

Family

ID=50492686

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310755425.9A Pending CN103735570A (zh) 2013-12-13 2013-12-13 一种预防口腔真菌感染的口腔护理液

Country Status (1)

Country Link
CN (1) CN103735570A (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107334781A (zh) * 2016-05-02 2017-11-10 南昌市第九医院 一种用于预防和治疗口腔真菌感染的药物
CN109513007A (zh) * 2018-12-13 2019-03-26 中国人民解放军总医院 泛酸钙在制备抗菌消炎药物中的应用
CN115192598A (zh) * 2022-09-13 2022-10-18 山东百多安医疗器械股份有限公司 一种用于缓解口角炎的敷贴
WO2024175393A1 (en) * 2023-02-22 2024-08-29 Unilever Ip Holdings B.V. Toothpaste composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101797262A (zh) * 2009-02-05 2010-08-11 齐凤芹 一种治疗小儿口腔溃疡的西药散剂

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101797262A (zh) * 2009-02-05 2010-08-11 齐凤芹 一种治疗小儿口腔溃疡的西药散剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘旭琴等: "两性霉素B联合碳酸氢钠漱口防治口腔真菌感染疗效观察", 《中华现代护理学杂志》, vol. 6, no. 18, 31 December 2009 (2009-12-31), pages 1667 - 1668 *
李定印: "利多卡因加复合维生素B和制霉菌素治疗儿童口腔溃疡临床观察", 《实用医技杂志》, vol. 13, no. 12, 30 June 2006 (2006-06-30), pages 2178 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107334781A (zh) * 2016-05-02 2017-11-10 南昌市第九医院 一种用于预防和治疗口腔真菌感染的药物
CN109513007A (zh) * 2018-12-13 2019-03-26 中国人民解放军总医院 泛酸钙在制备抗菌消炎药物中的应用
CN115192598A (zh) * 2022-09-13 2022-10-18 山东百多安医疗器械股份有限公司 一种用于缓解口角炎的敷贴
WO2024175393A1 (en) * 2023-02-22 2024-08-29 Unilever Ip Holdings B.V. Toothpaste composition

Similar Documents

Publication Publication Date Title
ES2565511T3 (es) Composiciones antisépticas, procedimientos y sistemas
CN105766990B (zh) 作为防腐剂用于农业、工业和其它用途的铋-硫醇
CN103735570A (zh) 一种预防口腔真菌感染的口腔护理液
CN108578268B (zh) 一种含有溶菌酶的牙膏
CN103932914A (zh) 壳聚糖漱口液及其制备方法
Akbulut et al. In vitro antimicrobial activity of different electrochemicallyactivated solutions on enterococcus faecalis
CN107096069A (zh) 羟基磷灰石包覆银纳米颗粒的核壳结构纳米复合材料及其制备方法
Yoo et al. Antifungal effects of synthetic human Beta-defensin-3-c15 peptide on Candida Albicans–infected root dentin
Alfei Shifting from Ammonium to Phosphonium Salts: A Promising Strategy to Develop Next-Generation Weapons against Biofilms
CN106727669A (zh) 一种高效温和的皮肤消毒凝胶及其制备方法
Marín-Correa et al. Nanosilver gel as an endodontic alternative against Enterococcus faecalis in an in vitro root canal system in Mexican dental specimens
CN103070881B (zh) 一种阴道抑菌、杀病毒组合物及其应用
CN102724872B (zh) 消毒剂组合物
CN105213215A (zh) 一种甲壳素护齿牙膏
CN101543506A (zh) 预防或治疗猪链球菌病的复方抗生素组合物
CN103766339A (zh) 含有反式肉桂醛的组合物
CN114569473B (zh) 一种环保型的免洗抑菌凝胶及其制备方法
US20060073156A1 (en) Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
Anand et al. A comparative analysis of antimicrobial property of wine and ozone with calcium hydroxide and chlorhexidine
CN106420938B (zh) 一种治疗口腔炎症及咽炎的中药组合物及其制备方法
WO2007092452A3 (en) Formulation and method of use for animal ear treatment and homeopathic animal ear treatment
RU2017145630A (ru) Композиции и способы для применения ламеллярных телец в терапевтических целях
Radeva et al. In Vitro Study of the Antibacterial Activity of Calcium Hydroxide on Candida Albicans
CN105030819A (zh) 一种3-羟基-4-吡啶酮类高分子铁螯合剂的用途
WO2015192260A1 (es) Formulación biocida para proteger la piel que comprende sales de cobre pentahidratado y sales de zinc heptahidratado

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140423